These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial. Nguyen LS; Squara P; Amour J; Carbognani D; Bouabdallah K; Thierry S; Apert-Verneuil C; Moyne A; Cholley B Crit Care; 2018 Aug; 22(1):193. PubMed ID: 30115103 [TBL] [Abstract][Full Text] [Related]
6. Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease. Hohneck AL; Fries P; Ströder J; Schneider G; Wagenpfeil S; Schirmer SH; Böhm M; Laufs U; Custodis F J Hypertens; 2019 May; 37(5):1023-1031. PubMed ID: 30672832 [TBL] [Abstract][Full Text] [Related]
7. Effects of Ivabradine on Heart Rate and Hemodynamic Parameters in a Swine Model of Cardiogenic Shock. Pascual Izco M; Castejón B; Piedras MJ; Zamorano JL; Sanmartín M; Zaragoza C Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1139-1141. PubMed ID: 28363707 [No Abstract] [Full Text] [Related]
8. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure. Cavusoglu Y; Mert U; Nadir A; Mutlu F; Morrad B; Ulus T J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):603-9. PubMed ID: 24922198 [TBL] [Abstract][Full Text] [Related]
9. Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure. Kakehi K; Iwanaga Y; Watanabe H; Sonobe T; Akiyama T; Shimizu S; Yamamoto H; Miyazaki S J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):387-396. PubMed ID: 30786751 [TBL] [Abstract][Full Text] [Related]
10. Clinical Experience with Ivabradine in Acute Heart Failure. Pascual Izco M; Alonso Salinas GL; Sanmartín Fernández M; Del Castillo Carnevalli H; Jiménez Mena M; Camino López A; Zamorano Gómez JL Cardiology; 2016; 134(3):372-4. PubMed ID: 27100325 [TBL] [Abstract][Full Text] [Related]
11. Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study. Steg P; Lopez-de-Sà E; Schiele F; Hamon M; Meinertz T; Goicolea J; Werdan K; Lopez-Sendon JL; Eur Heart J Acute Cardiovasc Care; 2013 Sep; 2(3):270-9. PubMed ID: 24222839 [TBL] [Abstract][Full Text] [Related]
12. Effects of Heart Rate Reduction With Either Pyridostigmine or Ivabradine in Patients With Heart Failure: A Randomized, Double-Blind Study. Villacorta AS; Villacorta H; Caldas JA; Precht BC; Porto PB; Rodrigues LU; Neves M; Xavier AR; Kanaan S; Mesquita CT; da Nóbrega ACL J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):139-145. PubMed ID: 30198318 [TBL] [Abstract][Full Text] [Related]
13. The hemodynamic effects of dobutamine during reoxygenation after hypoxia: a dose-response study in newborn pigs. Al-Salam Z; Johnson S; Abozaid S; Bigam D; Cheung PY Shock; 2007 Sep; 28(3):317-25. PubMed ID: 17545944 [TBL] [Abstract][Full Text] [Related]
14. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. Reil JC; Tardif JC; Ford I; Lloyd SM; O'Meara E; Komajda M; Borer JS; Tavazzi L; Swedberg K; Böhm M J Am Coll Cardiol; 2013 Nov; 62(21):1977-1985. PubMed ID: 23933545 [TBL] [Abstract][Full Text] [Related]
15. Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and β-Blockers. Bedet A; Voiriot G; Ternacle J; Marcos E; Adnot S; Derumeaux G; Mekontso Dessap A Anesthesiology; 2020 Feb; 132(2):321-329. PubMed ID: 31939847 [TBL] [Abstract][Full Text] [Related]
16. The role of heart rate and ivabradine in acute heart failure. Sciatti E; Vizzardi E; Bonadei I; Dallapellegrina L; Carubelli V Monaldi Arch Chest Dis; 2019 Oct; 89(3):. PubMed ID: 31594282 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure. Elzeneini M; Aranda JM; Al-Ani M; Ahmed MM; Parker AM; Vilaro JR Heart Fail Rev; 2021 Mar; 26(2):355-361. PubMed ID: 32997214 [TBL] [Abstract][Full Text] [Related]
18. Possible Ameliorative Effect of Ivabradine on the Autonomic and Left Ventricular Dysfunction Induced by Doxorubicin in Male Rats. El-Naggar AE; El-Gowilly SM; Sharabi FM J Cardiovasc Pharmacol; 2018 Jul; 72(1):22-31. PubMed ID: 29688913 [TBL] [Abstract][Full Text] [Related]
19. Beneficial Effects of Ivabradine on Post-Resuscitation Myocardial Dysfunction in a Porcine Model of Cardiac Arrest. Yang M; Chen L; Hua T; Zou Y; Yang Z Shock; 2020 May; 53(5):630-636. PubMed ID: 31274829 [TBL] [Abstract][Full Text] [Related]
20. Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression. Paterek A; Sochanowicz B; Oknińska M; Śmigielski W; Kruszewski M; Mackiewicz U; Mączewski M; Leszek P Biomed Pharmacother; 2021 Apr; 136():111250. PubMed ID: 33450487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]